Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-22 · accession 0001567619-22-020869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-23 | 2022-11-22 | TXG | McAnear Justin J. | CFO | S - Sale | $34.07 | -1,626 | 76.8K | -2% | -$55.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-22 | S | D | 686 | $34.07 | 77,704 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. (F2) Includes 1 share acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2022. |
| 2 | Common | Class A Common Stock | 2022-11-22 | S | D | 652 | $34.07 | 77,052 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
| 3 | Common | Class A Common Stock | 2022-11-22 | S | D | 288 | $34.07 | 76,764 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |